Ergoteles’s Urovant Sciences Ltd. UROV Stock Holding History

Ergoteles’s Portfolio UROV Stock Details UROV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-97,825	Closed	-$1.58M	–	1158
2020 Q4	$1.58M	Buy	+97,825	New	+$1.21M	0.05%	275

Ergoteles's UROV Position: Q1 2021 in Review

Ergoteles sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 97,825 shares — an estimated $1.58M sold.

Ergoteles first reported a position in UROV in Q4 2020 and held it in 1 quarter. The position peaked at $1.58M in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

Ergoteles reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
Ergoteles sold 97,825 Urovant Sciences Ltd. shares in Q1 2021, an estimated $1.58M.
Ergoteles first reported a position in Urovant Sciences Ltd. in Q4 2020 and held it in 1 quarter.
Ergoteles's Urovant Sciences Ltd. position peaked at $1.58M in Q4 2020.
0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Ergoteles's 13F filing for Q1 2021, filed 12 May 2021.